9
Views
5
CrossRef citations to date
0
Altmetric
Original Articles

Preparation and Physico-Chemical Studies of Some Novel Mixed-Ligand Cyanonitrosyl {CrNO}5 Complexes of Chromium(I) with Some Antimalarial, Antibacterial and Antidyspeptic Drugs

&
Pages 1627-1639 | Received 14 Dec 1990, Accepted 03 Sep 1991, Published online: 23 Sep 2006
 

Abstract

A new series of mixed-ligand cyanonitrosyl {CrNO}5 complexes of chromium(I) of compositions [Cr(NO)(CN)2(L-L)(H2O)] (where L-L = primaquine diphosphate, camoquin dihydrochloride, quinine monohydrochloride, cinchonine monohydrochloride, chloroquine diphosphate or chloroquinaldol) and [Cr(NO)(CN)2(L)2(HO)](where L = bilamide) hare been synthesized by the interaction of the potassium pentacyanonitrosylchromate(I) mnnohydrate with the said drugs L-L and L. The complexes so obtained are characterized by elemental analyses, molar conductances, magnetic measurements, thermogravi-metric analysis, electron spin resonance and infra-red spectral studies. The over all I. R. spectral studies suggest that all the liganda (except bilamide which behaves as monodentate) behave as bidentate ligands. The complexes are thermally stable up to 300°c, are paramagnetic with respect to one unpaired electron and give a positive Griess reagent test. Chromium(I) contains the low-spin {CrNO}5 electron configuration in all the complexes.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.